Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 8Hepatitis B, Chronic 5Hepatitis B 4Fibrosis 3Lymphoma 2Virus Diseases 1Recurrence 1Paraparesis, Tropical Spastic 1Neuritis 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Liver Cirrhosis 1Leukemia-Lymphoma, Adult T-Cell 1Infections 1Hepatitis D 1HTLV-I Infections 1Esophageal and Gastric Varices 1Epstein-Barr Virus Infections 1Burkitt Lymphoma 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 9Ciprofloxacin 8Voriconazole 5Vancomycin 4Caspofungin 4Amoxicillin-Potassium Clavulanate Combination 4gamma-Globulins 3Fluconazole 3Filgrastim 3Daptomycin 3Antibiotic Prophylaxis 3plerixafor 2liposomal amphotericin B 2Whole-Body Irradiation 2Trimethoprim 2Therapeutics 2Sulfamethoxazole 2Saline Solution 2Ribavirin 2Polymerase Chain Reaction 2Piperacillin, Tazobactam Drug Combination 2Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2Moxifloxacin 2Melphalan 2Levofloxacin 2Lenalidomide 2Itraconazole 2Immunoglobulins, Intravenous 2Granulocyte Colony-Stimulating Factor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Tenofovir × Clear all
NCT07133776 2025-08-21

Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

The Affiliated Hospital of Xuzhou Medical University

Phase 1/2 Not yet recruiting
30 enrolled

Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡